ScreenerHero

IMDX Insight Molecular Diagnostics Inc.

NAS · US · Healthcare · Diagnostics & Research · imdxinc.com
3.460USD+2.37%Mkt Cap: 113.23M $P/E: —

Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests,…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$244.79BUSDP/E 36.7
DHR
Danaher Corporation
$153.60BUSDP/E 38.9
NTRA
Natera, Inc.
$57.02BUSD
LONN
Lonza Group AG
$46.01BUSDP/E 38.3
A
Agilent Technologies, Inc.
$47.67BUSDP/E 33.4
WAT
Waters Corporation
$42.81BUSDP/E 110.4
IQV
IQVIA Holdings Inc.
$42.48BUSDP/E 32.1
ILMN
Illumina, Inc.
$40.43BUSDP/E 50.0
IDXX
IDEXX Laboratories, Inc.
$39.97BUSDP/E 35.6
MTD
Mettler-Toledo International Inc.
$30.73BUSDP/E 34.6
LH
Labcorp Holdings Inc.
$25.30BUSDP/E 25.8
DGX
Quest Diagnostics Incorporated
$25.06BUSDP/E 24.1
GH
Guardant Health, Inc.
$22.59BUSD
RVTY
Revvity, Inc.
$17.14BUSDP/E 73.5
MEDP
Medpace Holdings, Inc.
$16.87BUSDP/E 35.5
ERF
Eurofins Scientific SE
$14.23BUSDP/E 26.6
CRL
Charles River Laboratories International, Inc.
$14.34BUSD
ICLR
ICON Public Limited Company
$12.66BUSDP/E 172.7
BIM
bioMérieux S.A.
$10.35BUSDP/E 20.7
QGEN
Qiagen N.V.
$9.25BUSDP/E 22.7

Key Statistics

Company
Market Cap113.23M USD
Enterprise Value95.48M USD
Revenue (TTM)1.67M USD
Gross Profit2.30M USD
Net Income (TTM)-50.22M USD
Revenue/Share0.05 USD
Last Price3.460 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees55
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.22
PEG—
EV/EBITDA-2.76
EV/Revenue57.17
P/S66.23
P/B-5.18
EPS (TTM)-1.40
EPS (Forward)-0.80
52W Range
2.42017% of range8.510
52W High8.510 USD
52W Low2.420 USD
Profitability
Gross Margin56.67%
Oper. Margin-3815.06%
EBITDA Margin0.00%
Profit Margin-1238.52%
ROE159.62%
ROA-194.99%
Growth
Revenue Growth-53.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-22.18M USD
CapEx (TTM)3.19M USD
FCF Margin-1125.12%
FCF Yield-16.59%
Net Debt-15.13M USD
Net Debt/EBITDA0.44
Balance Sheet
Debt/Equity-0.11
Current Ratio2.00
Quick Ratio1.75
Book Value/Sh-0.65 USD
Cash/Share0.54 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateJul 25, 2023
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)8.250 USD
Upside (mean)+138.4%
Target Range4.000 USD – 12.00 USD
4.000+138.4% to mean12.00
# Analysts4
Ownership
Shares Out.32.72M
Float9.98M
Insiders21.00%
Institutions56.43%
Short Interest
Short Ratio6.2d
Short % Float6.10%
Short % Out.3.03%
Shares Short992.47K
Short (prev mo.)1.09M
Technical
SMA 504.186 (-17.3%)
SMA 2005.068 (-31.7%)
Beta1.80
S&P 52W Chg16.45%
Avg Vol (30d)258.37K
Avg Vol (10d)388.86K
Technical Indicators
RSI (14)40.8
MACD-0.2371
MACD Signal-0.2259
MACD Hist.-0.0112
BB Upper4.453 USD
BB Middle3.804 USD
BB Lower3.156 USD
BB Width34.12%
ATR (14)0.3985 USD
Vol Ratio (20d)0.46x